trueguide modified synthetic sgrnas Search Results


99
Integrated DNA Technologies pre assembled cas9 rnp
Pre Assembled Cas9 Rnp, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/High-fidelity+Cas9+nuclease/pmc08832378-571-1-6
Average 99 stars, based on 1 article reviews
pre assembled cas9 rnp - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

86
Synthego Inc synthetic single guide rna sgrna
Synthetic Single Guide Rna Sgrna, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/guide+rna+single/pm41381412-211-14-41
Average 86 stars, based on 1 article reviews
synthetic single guide rna sgrna - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Synthego Inc synthetic sgrna
Synthetic Sgrna, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/sgrna+synthetic/pmc12807513-52-7-9
Average 86 stars, based on 1 article reviews
synthetic sgrna - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

93
Addgene inc gecko sgrna human library
Gecko Sgrna Human Library, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/Human+GeCKO+library+(Pooled+library+%2351241)/pmc09162922-27-11-15
Average 93 stars, based on 1 article reviews
gecko sgrna human library - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
GenScript corporation chemical modified synthetic sgrna
TadA library screening and efficiency plasmid testing. a) The E. Coli TadA8e (green and cyans) structure with spCas9 (orange) and DNA (blue and magenta). The mutant amino acids were red and lemon sticks. The protein data is from RCSB: ABE8e (6VPC). b) The library screening process. LTR is lentivirus parts. EF1α is ABE and EGFP's promotor. U6 is <t>sgRNA's</t> promotor. A BsmBI enzyme cutting site has been designed on TadA. c) The amino acids of Mut14, Mut 15, Mut25, and Mut32 compared to ABE8e. d) ABE8e and 31 mutants’ base editing results in HEK293T at nine genetic sites. Each mutant data is compared with ABE8e to show the A to G efficiency increasing ratio. The base editing frequencies are shown in Figure (Supporting Information). e) Average A‐to‐G editing frequencies of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, TadA8e‐Mut32, ABE9, and ABE9e. f. Adenine and cytosine editing efficiency of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, and TadA8e‐Mut32 at FANCF‐sg1 site. All data have three independent biological replicates (mean ± SD).
Chemical Modified Synthetic Sgrna, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/chemically+modified+sgrna/pmc11321652-144-1-18
Average 90 stars, based on 1 article reviews
chemical modified synthetic sgrna - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
TriLink chemically modified synthetic sgrna
TadA library screening and efficiency plasmid testing. a) The E. Coli TadA8e (green and cyans) structure with spCas9 (orange) and DNA (blue and magenta). The mutant amino acids were red and lemon sticks. The protein data is from RCSB: ABE8e (6VPC). b) The library screening process. LTR is lentivirus parts. EF1α is ABE and EGFP's promotor. U6 is <t>sgRNA's</t> promotor. A BsmBI enzyme cutting site has been designed on TadA. c) The amino acids of Mut14, Mut 15, Mut25, and Mut32 compared to ABE8e. d) ABE8e and 31 mutants’ base editing results in HEK293T at nine genetic sites. Each mutant data is compared with ABE8e to show the A to G efficiency increasing ratio. The base editing frequencies are shown in Figure (Supporting Information). e) Average A‐to‐G editing frequencies of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, TadA8e‐Mut32, ABE9, and ABE9e. f. Adenine and cytosine editing efficiency of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, and TadA8e‐Mut32 at FANCF‐sg1 site. All data have three independent biological replicates (mean ± SD).
Chemically Modified Synthetic Sgrna, supplied by TriLink, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/chemically+synthesized+sgrna/pmc05826598-129-11-18
Average 90 stars, based on 1 article reviews
chemically modified synthetic sgrna - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Synthego Inc synthetic single guide rnas
TadA library screening and efficiency plasmid testing. a) The E. Coli TadA8e (green and cyans) structure with spCas9 (orange) and DNA (blue and magenta). The mutant amino acids were red and lemon sticks. The protein data is from RCSB: ABE8e (6VPC). b) The library screening process. LTR is lentivirus parts. EF1α is ABE and EGFP's promotor. U6 is <t>sgRNA's</t> promotor. A BsmBI enzyme cutting site has been designed on TadA. c) The amino acids of Mut14, Mut 15, Mut25, and Mut32 compared to ABE8e. d) ABE8e and 31 mutants’ base editing results in HEK293T at nine genetic sites. Each mutant data is compared with ABE8e to show the A to G efficiency increasing ratio. The base editing frequencies are shown in Figure (Supporting Information). e) Average A‐to‐G editing frequencies of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, TadA8e‐Mut32, ABE9, and ABE9e. f. Adenine and cytosine editing efficiency of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, and TadA8e‐Mut32 at FANCF‐sg1 site. All data have three independent biological replicates (mean ± SD).
Synthetic Single Guide Rnas, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/guide+rnas/10__1158_slash_0008___5472__can___25___0018-69-10-6
Average 86 stars, based on 1 article reviews
synthetic single guide rnas - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Synthego Inc synthetic modified sgrnas
LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells <t>were</t> <t>transfected</t> with scramble sgRNA or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected with <t>sgRNAs</t> targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.
Synthetic Modified Sgrnas, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/modified+sgrna+synthetic/bio_rxiv__2025__11__05__684493-239-0-3
Average 86 stars, based on 1 article reviews
synthetic modified sgrnas - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Synthego Inc synthetic sgrna oligos
LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells <t>were</t> <t>transfected</t> with scramble sgRNA or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected with <t>sgRNAs</t> targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.
Synthetic Sgrna Oligos, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/oligos+sgrna/bio_rxiv__64898__2026__03__17__711757-251-5-30
Average 86 stars, based on 1 article reviews
synthetic sgrna oligos - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Synthego Inc synthetic sgrnas
LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells <t>were</t> <t>transfected</t> with scramble sgRNA or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected with <t>sgRNAs</t> targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.
Synthetic Sgrnas, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/sgrnas+synthetic/pmc09029233-535-6-9
Average 86 stars, based on 1 article reviews
synthetic sgrnas - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
GenScript corporation modified sgrna cassettes
LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells <t>were</t> <t>transfected</t> with scramble sgRNA or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected with <t>sgRNAs</t> targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.
Modified Sgrna Cassettes, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/grna+expression+cassette/pmc09728512__SC___013___D2SC04656C___s001-64-4-8
Average 90 stars, based on 1 article reviews
modified sgrna cassettes - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
GenScript corporation modified synthetic sgrna
LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells <t>were</t> <t>transfected</t> with scramble sgRNA or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected with <t>sgRNAs</t> targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.
Modified Synthetic Sgrna, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trueguide+modified+synthetic+sgrnas/synthetic+sgrnas/pmc11749481-149-2-24
Average 90 stars, based on 1 article reviews
modified synthetic sgrna - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


TadA library screening and efficiency plasmid testing. a) The E. Coli TadA8e (green and cyans) structure with spCas9 (orange) and DNA (blue and magenta). The mutant amino acids were red and lemon sticks. The protein data is from RCSB: ABE8e (6VPC). b) The library screening process. LTR is lentivirus parts. EF1α is ABE and EGFP's promotor. U6 is sgRNA's promotor. A BsmBI enzyme cutting site has been designed on TadA. c) The amino acids of Mut14, Mut 15, Mut25, and Mut32 compared to ABE8e. d) ABE8e and 31 mutants’ base editing results in HEK293T at nine genetic sites. Each mutant data is compared with ABE8e to show the A to G efficiency increasing ratio. The base editing frequencies are shown in Figure (Supporting Information). e) Average A‐to‐G editing frequencies of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, TadA8e‐Mut32, ABE9, and ABE9e. f. Adenine and cytosine editing efficiency of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, and TadA8e‐Mut32 at FANCF‐sg1 site. All data have three independent biological replicates (mean ± SD).

Journal: Advanced Science

Article Title: Library‐Assisted Evolution in Eukaryotic Cells Yield Adenine Base Editors with Enhanced Editing Specificity

doi: 10.1002/advs.202309004

Figure Lengend Snippet: TadA library screening and efficiency plasmid testing. a) The E. Coli TadA8e (green and cyans) structure with spCas9 (orange) and DNA (blue and magenta). The mutant amino acids were red and lemon sticks. The protein data is from RCSB: ABE8e (6VPC). b) The library screening process. LTR is lentivirus parts. EF1α is ABE and EGFP's promotor. U6 is sgRNA's promotor. A BsmBI enzyme cutting site has been designed on TadA. c) The amino acids of Mut14, Mut 15, Mut25, and Mut32 compared to ABE8e. d) ABE8e and 31 mutants’ base editing results in HEK293T at nine genetic sites. Each mutant data is compared with ABE8e to show the A to G efficiency increasing ratio. The base editing frequencies are shown in Figure (Supporting Information). e) Average A‐to‐G editing frequencies of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, TadA8e‐Mut32, ABE9, and ABE9e. f. Adenine and cytosine editing efficiency of ABE8e, TadA8e‐Mut14, TadA8e‐Mut15, TadA8e‐Mut25, and TadA8e‐Mut32 at FANCF‐sg1 site. All data have three independent biological replicates (mean ± SD).

Article Snippet: The chemical‐modified synthetic sgRNA (2′‐O‐methyl 3′ phosphorothioate modifications in the first and last three nucleotides) was ordered from GenScript.

Techniques: Library Screening, Plasmid Preparation, Mutagenesis

LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells were transfected with scramble sgRNA or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected with sgRNAs targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.

Journal: bioRxiv

Article Title: An InDel Genomic Variant within a Bifunctional Super-Enhancer for LINC00636 and CD47 Regulation in Breast Cancer

doi: 10.1101/2025.11.05.684493

Figure Lengend Snippet: LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells were transfected with scramble sgRNA or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected with sgRNAs targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.

Article Snippet: Synthetic modified sgRNAs (Synthego) for the target region or negative control were transfected at a final concentration of 50nM using TransIT-X2 Dynamic Delivery System (MIR 6004, Mirus) following manufacturer’s instructions.

Techniques: RNA Expression, Inhibition, Control, Activation Assay, Expressing, Transfection, Over Expression